{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:19:53Z","timestamp":1789154393297,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,12,26]],"date-time":"2012-12-26T00:00:00Z","timestamp":1356480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00595-012-0462-8","type":"journal-article","created":{"date-parts":[[2012,12,24]],"date-time":"2012-12-24T19:21:40Z","timestamp":1356376900000},"page":"289-292","source":"Crossref","is-referenced-by-count":30,"title":["A rare point mutation in the Ras oncogene in hepatocellular carcinoma"],"prefix":"10.1007","volume":"43","author":[{"given":"Akinobu","family":"Taketomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Shirabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Yoshiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Mano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoharu","family":"Yoshizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sugio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,26]]},"reference":[{"key":"462_CR1","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB Serag El","year":"2007","unstructured":"El Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557\u201376.","journal-title":"Gastroenterology"},{"key":"462_CR2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2169\/internalmedicine.45.1531","volume":"45","author":"K Okita","year":"2006","unstructured":"Okita K. Clinical aspects of hepatocellular carcinoma in Japan. Intern Med. 2006;45:229\u201333.","journal-title":"Intern Med"},{"key":"462_CR3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jamcollsurg.2007.01.035","volume":"204","author":"A Taketomi","year":"2007","unstructured":"Taketomi A, Kitagawa D, Itoh S, Harimoto N, Yamashita Y, Gion T, et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute\u2019s experience with 625 patients. J Am Coll Surg. 2007;204:580\u20137.","journal-title":"J Am Coll Surg"},{"key":"462_CR4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/TP.0b013e3181943bee","volume":"87","author":"A Taketomi","year":"2009","unstructured":"Taketomi A, Sanefuji K, Soejima Y, Yoshizumi T, Uhciyama H, Ikegami T, et al. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation. 2009;87:531\u20137.","journal-title":"Transplantation"},{"key":"462_CR5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-2005-871198","volume":"25","author":"JM Llovet","year":"2005","unstructured":"Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005;25:181\u2013200.","journal-title":"Semin Liver Dis"},{"key":"462_CR6","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/hep.22506","volume":"48","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology. 2008;48:1312\u201327.","journal-title":"Hepatology"},{"key":"462_CR7","doi-asserted-by":"crossref","unstructured":"Abou Alfa GK, Schwartz L, Ricci S, Amadori D, Santoro A, Figer A, et al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol. 2006;24:4293\u2013300.","DOI":"10.1200\/JCO.2005.01.3441"},{"key":"462_CR8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378\u201390.","journal-title":"N Engl J Med"},{"key":"462_CR9","first-page":"2903","volume":"52","author":"K Sugio","year":"1992","unstructured":"Sugio K, Ishida T, Yokoyama H, Inoue T, Sugimachi K, Sasazuki T. Ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res. 1992;52:2903\u20136.","journal-title":"Cancer Res"},{"key":"462_CR10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1349-7006.1989.tb02290.x","volume":"80","author":"H Tsuda","year":"1989","unstructured":"Tsuda H, Hirohashi S, Shimosato Y, Ino Y, Yoshida T, Terada M. Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma. Jpn J Cancer Res. 1989;80:196\u20139.","journal-title":"Jpn J Cancer Res"},{"key":"462_CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10147-010-0083-4","volume":"15","author":"S Tanaka","year":"2010","unstructured":"Tanaka S, Arii S. Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science. Int J Clin Oncol. 2010;15:235\u201341.","journal-title":"Int J Clin Oncol"},{"key":"462_CR12","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1038\/cddis.2011.34","volume":"2","author":"M Caraglia","year":"2011","unstructured":"Caraglia M, Giuberti G, Marra M, Addeo R, Montella L, Murolo M, et al. Oxidative stress and ERK1\/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. Cell Death Dis. 2011;2:e150.","journal-title":"Cell Death Dis"},{"key":"462_CR13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-7-41","volume":"7","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, Zhou X, Shen H, Wang D, Wang Y. Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study. BMC Med. 2009;7:41.","journal-title":"BMC Med"},{"key":"462_CR14","first-page":"1121","volume":"50","author":"M Tada","year":"1990","unstructured":"Tada M, Omata M, Ohto M. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Cancer Res. 1990;50:1121\u20134.","journal-title":"Cancer Res"},{"key":"462_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/hep.1840130106","volume":"13","author":"N Ogata","year":"1991","unstructured":"Ogata N, Kamimura T, Asakura H. Point mutation, allelic loss and increased methylation of c-Ha-ras gene in human hepatocellular carcinoma. Hepatology. 1991;13:31\u20137.","journal-title":"Hepatology"},{"key":"462_CR16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0168-8278(92)90181-N","volume":"14","author":"C Challen","year":"1992","unstructured":"Challen C, Guo K, Collier JD, Cavanagh D, Bassendine MF. Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas. J Hepatol. 1992;14:342\u20136.","journal-title":"J Hepatol"},{"key":"462_CR17","first-page":"859","volume":"15","author":"M Leon","year":"1995","unstructured":"Leon M, Kew MC. Analysis of ras gene mutations in hepatocellular carcinoma in southern African blacks. Anticancer Res. 1995;15:859\u201361.","journal-title":"Anticancer Res"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-012-0462-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-012-0462-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-012-0462-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:05:26Z","timestamp":1559124326000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-012-0462-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,26]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["462"],"URL":"https:\/\/doi.org\/10.1007\/s00595-012-0462-8","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,26]]}}}